AKT1 and neoplasm: In a previous study involving mouse models and human samples, proteins produced by CAFs from tumor tissues, such as kynurenine, activated the downstream AKT and extracellular signal-regulated kinase (ERK) pathways, contributing to EGFR-TKI resistance [155].